2 citations
,
February 2021 in “The Journal of clinical and aesthetic dermatology” This review examines the various potential causes of bitemporal hair loss, emphasizing the importance of prompt diagnosis to prevent further hair loss in scarring conditions; it reports no new clinical results.
1 citations
,
May 2022 in “Archiv Euromedica” This report discusses a case where pregnancy triggered the development of folliculitis decalvans, highlighting that systemic treatments are typically avoided during pregnancy in favor of topical medication.
1 citations
,
June 2014 in “Serbian Journal of Dermatology and Venereology” This case report describes a 22-year-old woman initially suspected of alopecia areata, whose scalp lesions were ultimately diagnosed as discoid lupus erythematosus after histopathological analysis.
January 2026 in “Acta Dermatovenerologica Alpina Pannonica et Adriatica” In this study, cicatricial alopecias were classified by inflammatory cell type and the researchers highlighted that primary cicatricial alopecia's exact causes remain unknown, accounting for 6% of all hair diseases despite its unclear prevalence.
This review provides an overview of the etiology, presentation, and diagnosis of steatocystomas, including subtypes and complications, while detailing their history, epidemiology, and management strategies.
February 2024 in “Acta dermato-venereologica” This study reports that folliculitis decalvans and lichen planopilaris phenotypic spectrum is an underdiagnosed form of cicatricial alopecia, potentially treatable with anti-inflammatory drugs used for lichen planopilaris.
February 2024 in “International journal of medical science and clinical research studies” This article reviews the clinical features, pathogenesis, and treatment strategies for Central Centrifugal Cicatricial Alopecia, emphasizing the need for enhanced understanding and early diagnosis, but reports no new research findings.
July 2023 in “International journal of dermatology, venereology and leprosy sciences” In this study of 50 rural children with tinea capitis, 64% had the non-inflammatory type, while 28% had the inflammatory type, with most cases showing positive results in KOH examinations.
October 2022 in “JAAD international” This study found that more than 70% of patients with autoimmune blistering diseases experienced alopecia, with about 10% having scarring alopecia, and elevated Dsg1 ratios were linked to hair loss in pemphigus vulgaris.
January 2020 in “Clinical dermatology open access journal” This study highlights the variation in clinical findings of traction alopecia and emphasizes that changes in hairstyles may prevent progression to scarring alopecia.
April 2019 in “The journal of investigative dermatology/Journal of investigative dermatology” This study found that low image resolutions allow expert clinicians to detect alopecia, but higher resolutions are necessary for identifying scarring and vellus hair, which may inform future image processing algorithms in dermatology.
In this study, chronic telogen effluvium was identified as the most common cause of alopecia in patients with systemic lupus erythematosus, with trichoscopy proving effective in diagnosing different alopecia patterns.
109 citations
,
May 2011 in “Dermatologic Therapy” This article reviews the characteristics, associations, and diagnostic criteria for alopecia areata and reports no new clinical findings; the authors note the disease's unpredictable course and variable prognosis.
20 citations
,
February 2019 in “Genes” This study identifies a likely pathogenic homozygous missense variant in the AEBP1 gene in a patient with symptoms of classical Ehlers-Danlos syndrome, suggesting new perspectives for EDS classification and research.
3 citations
,
October 2019 in “JAAD Case Reports” This review discusses different forms and patterns of alopecia associated with lupus erythematosus and reports no new clinical results; the authors highlight distinct features of these conditions.
2 citations
,
January 2019 in “Case Reports in Dermatology” In this rare case report, the researchers described a 66-year-old African woman with lipedematous alopecia, highlighting its clinical features, the significance of palpation in examinations, and the uncertainty of it being a distinct disease entity or a combination of two conditions.
1 citations
,
September 2025 in “JAAD reviews.” This review discusses the condition alopecia areata and summarizes its available treatments, mentioning three recently approved Janus kinase inhibitors, but reports no new clinical results.
1 citations
,
October 2020 in “International Journal of Research in Dermatology” This study found that short vellus hair and yellow dots are common dermoscopic findings in alopecia areata, with variations indicating disease activity or remission.
December 2025 in “EXPERIMENTAL & CLINICAL MEDICINE GEORGIA” This study describes Pseudopelade of Brocq as a rare and enigmatic scarring alopecia characterized by irregular hair loss patterns on the scalp, requiring exclusion of other conditions like lichen planopilaris and discoid lupus erythematosus for a specific diagnosis.
In this study, trichoscopy was found to be a valuable non-invasive tool for diagnosing scalp lesions, enhancing diagnostic accuracy and reducing the need for scalp biopsies by identifying specific trichoscopic features associated with conditions like psoriasis, seborrheic dermatitis, and alopecia areata.
May 2025 in “Skin Appendage Disorders” This review reports that psoriatic alopecia, a type of hair loss linked to psoriasis, is difficult to diagnose and often resistant to conventional treatments, highlighting the need for further research into its immune-related mechanisms and personalized treatment approaches for better management.
September 2024 in “Kuban Scientific Medical Bulletin” In this paper, three cases illustrate the diagnostic challenges of distinguishing between scarring and non-scarring alopecia, emphasizing the importance of thorough examinations and pathological evaluation to accurately diagnose hair disorders and initiate timely treatment.
December 2023 in “EPRA international journal of multidisciplinary research” In this review, researchers examined current knowledge on alopecia areata, finding it affects approximately 2% of individuals, with a likely autoimmune and genetic basis, and highlighting its association with other medical and psychiatric conditions, although no cure currently exists.
June 2019 in “Pediatric Dermatology” This review discusses the pathogenesis and clinical presentations of alopecia in epidermolysis bullosa patients, noting diverse hair abnormalities and emphasizing the lack of a consensus on its natural history.
48 citations
,
February 2017 in “Journal of Cosmetic Dermatology” This proposal reviews current knowledge and suggests actions for managing chemotherapy‐induced alopecia but reports no new clinical results, highlighting the need for evidence‐based guidelines.
36 citations
,
June 2018 in “Journal of The American Academy of Dermatology” This review examines the increasing clinical applications of dermoscopy in diagnosing various skin conditions and highlights its potential to improve diagnostic accuracy and reduce unnecessary histologic confirmation.
24 citations
,
March 1998 in “Mycoses” In this study, 31 children with kerion Celsi were treated successfully with antifungal medications, emphasizing the importance of early diagnosis and treatment to prevent scarring and hair loss.
9 citations
,
September 2010 in “Dermatologic therapy” This study found that combined therapy with cetirizine and topical steroids stabilized inflammation in most patients with lichen planus pilaris, though one patient experienced cardiac arrhythmia.
1 citations
,
November 2016 in “International Journal of Research in Dermatology” This study concluded that there was no statistically significant correlation between clinical, histopathological, and immunofluorescence findings in cases of cicatricial alopecia.
December 2025 in “Actas Dermo-Sifiliográficas” This consensus from 22 Spanish dermatologists recommends using a multimodal therapy starting with oral dutasteride, combined with topical and/or intralesional agents, and adding hydroxychloroquine if inflammation persists, to manage frontal fibrosing alopecia due to its irreversible hair loss and lack of specific approved treatments.